Identification of a novel immune-related transcriptional regulatory network in sarcopenia
Authors:
Open Access
- 31 July 2023
- journal article
- research article
- Published by Springer Nature in BMC Geriatrics
- Vol. 23 (1) , 1-16
Abstract
Background: Sarcopenia is highly prevalent in elderly individuals and has a significant adverse effect on their physical health and quality of life, but the mechanisms remain unclear. Studies have indicated that transcription factors (TFs) and the immune microenvironment play a vital role in skeletal muscle atrophy. Methods: RNA-seq data of 40 muscle samples were downloaded from the GEO database. Then, differentially expressed genes (DEGs), TFs(DETFs), pathways(DEPs), and the expression of immune gene sets were identified with limma, edgeR, GO, KEGG, ORA, GSVA, and ssGSEA. Furthermore, the results above were integrated into coexpression analysis by Pearson correlation analysis (PCA). Significant coexpression patterns were used to construct the immune-related transcriptional regulatory network by Cytoscape and potential medicine targeting the network was screened by Connectivity Map. Finally, the regulatory mechanisms and RNA expression of DEGs and DETFs were identified by multiple online databases and RT‒qPCR. Results: We screened 808 DEGs (log2 fold change (FC) > 1 or < − 1, p < 0.05), 4 DETFs (log2FC > 0.7 or < − 0.7, p < 0.05), 304 DEPs (enrichment scores (ES) > 1 or < − 1, p < 0.05), and 1208 differentially expressed immune genes sets (DEIGSs) (p < 0.01). Based on the results of PCA (correlation coefficient (CC) > 0.4 or < − 0.4, p < 0.01), we then structured an immune-related network with 4 DETFs, 9 final DEGs, 11 final DEPs, and 6 final DEIGSs. Combining the results of online databases and in vitro experiments, we found that PAX5-SERPINA5-PI3K/Akt (CC ≤ 0.444, p ≤ 0.004) was a potential transcriptional regulation axis, and B cells (R = 0.437, p = 0.005) may play a vital role in this signal transduction. Finally, the compound of trichostatin A (enrichment = -0.365, specificity = 0.4257, p < 0.0001) might be a potential medicine for sarcopenia based on the PubChem database and the result of the literature review. Conclusions: We first identified immune-related transcriptional regulatory network with high-throughput RNA-seq data in sarcopenia. We hypothesized that PAX5-SERPIAN5-PI3K/Akt axis is a potential mechanism in sarcopenia and that B cells may play a vital role in this signal transduction. In addition, trichostatin A might be a potential medicine for sarcopenia.Keywords
All Related Versions
Funding Information
- National Natural Science Foundation of China (81770884, 82171565)
This publication has 40 references indexed in Scilit:
- Pathway-focused genetic evaluation of immune and inflammation related genes with chronic fatigue syndromeHuman Immunology, 2015
- Antibody-independent functions of B cells: a focus on cytokinesNature Reviews Immunology, 2015
- Histone deacetylase inhibitor trichostatin A enhances myogenesis by coordinating muscle regulatory factors and myogenic repressorsBiochemical and Biophysical Research Communications, 2011
- Pax52011
- Protein–DNA array-based identification of transcription factor activities differentially regulated in skeletal muscle of normal and dystrophin-deficient mdx miceMolecular and Cellular Biochemistry, 2008
- Transcription Factor Pax5 Activates the Chromatin of Key Genes Involved in B Cell Signaling, Adhesion, Migration, and Immune FunctionImmunity, 2007
- Characterization of a novel human protein C inhibitor (PCI) gene transgenic mouse useful for studying the role of PCI in physiological and pathological conditionsJournal of Thrombosis and Haemostasis, 2004
- Angiogenic signal triggered by ischemic stress induces myocardial repair in rat during chronic infarctionJournal of Molecular and Cellular Cardiology, 2004
- Association Between Chronic Fatigue Syndrome and the Corticosteroid‐Binding Globulin Gene ALA SER224PolymorphismEndocrine Research, 2004
- Transcription factors and muscle cachexia: is there a therapeutic target?The Lancet, 2001